ALTACE Side Effects

6835452-0 | Renal Failure Acute
on Jul 07, 2010 Female patient from GERMANY , 36 years of age, weighting 132.3 lb, was diagnosed with chills and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with VANCOMYCIN (1000 Mg, Bid) (View Vancomycin Review and Vancomycin Label ), TAZOBAC (1 Df, Tid) (View Tazobac Review and Tazobac Label ). Patient was hospitalized.

6830616-4 | Fall, Thrombocytopenia
Patient was taking Altace (View Usage). Patient had the following side effects: fall (What is fall?), thrombocytopenia on Jul 02, 2010 from FRANCE Additional patient health information: Male patient , 91 years of age, . Altace dosage: Unk. During the same period patient was treated with DIAMICRON (Unk) (View Diamicron Review and Diamicron Label ), CELECTOL (View Celectol Review and Celectol Label ), PROSCAR (View Proscar Review and Proscar Label ), TELFAST (View Telfast Review and Telfast Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6830615-2 | Dry Mouth, Fibromyalgia, Lip Pain, Swollen Tongue
Adverse event was reported on Jul 01, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with hypertension, sleep disorder (What is sleep disorder?), depression (What is depression?) and. Location: GERMANY , 67 years of age, After Altace was administered, patient had the following side effects: dry mouth, fibromyalgia, lip pain, swollen tongue. During the same period patient was treated with STANGYL (100 Mg, Qd) (View Stangyl Review and Stangyl Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), TRAMADOL HCL (Unk) (View Tramadol Hcl Review and Tramadol Hcl Label ), DULOXETINE HYDROCHLORIDE (Unk) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ). Patient was hospitalized and became disabled.

6830609-7 | Auricular Swelling, Eosinophilia, Pruritus, Swelling Face
on Jul 06, 2010 Female patient from FRANCE , 78 years of age, was diagnosed with hypertension, mitral valvotomy and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: auricular swelling, eosinophilia, pruritus, swelling face. Altace dosage: 1 Df, Qd. During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ), CARDENSIEL (1 Df, Qd) (View Cardensiel Review and Cardensiel Label ), LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ). Patient was hospitalized.


6830608-5 | Convulsion, Feeling Hot, Gait Disturbance, Hyponatraemia, Memory Impairment, Neurological Symptom, Osmotic Demyelination Syndrome, Thirst
on Jul 06, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with hypertension, depression (What is depression?), tooth disorder (What is tooth disorder?) and was treated with Altace (View Usage). Patient had the following side effects: convulsion, feeling hot, gait disturbance, hyponatraemia, memory impairment, neurological symptom, osmotic demyelination syndrome, thirst. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), METRONIDAZOLE (200 Mg, Tid) (View Metronidazole Review and Metronidazole Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), GARLIC (View Garlic Review and Garlic Label ), MENOPACE (View Menopace Review and Menopace Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized and became disabled.

6822039-9 | Myelodysplastic Syndrome
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: myelodysplastic syndrome on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 80 years of age, was diagnosed with hypertension and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with ISCOVER (View Iscover Review and Iscover Label ), DIBLOCIN PP (View Diblocin Pp Review and Diblocin Pp Label ), INSULIN ACTRAPHANE (View Insulin Actraphane Review and Insulin Actraphane Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6822038-7 | Laryngospasm
Adverse event was reported on Jun 30, 2010 by a Male patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with hypertension and. Location: ITALY , 47 years of age, Patient experienced the following unwanted or unexpected effects: laryngospasm. During the same period patient was treated with HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6810202-2 | Blood Creatinine Increased, Confusional State, Dehydration, Disorientation, Mania, Personality Change, Renal Disorder, Renal Failure Acute
on Jun 23, 2010 Male patient from GERMANY , 77 years of age, was diagnosed with hypertension, arthralgia and was treated with Altace (View Usage). Patient had the following side effects: blood creatinine increased, confusional state, dehydration, disorientation, mania, personality change, renal disorder, renal failure acute. Altace dosage: 5 Mg, Bid. During the same period patient was treated with ARCOXIA (90 Mg, Qd) (View Arcoxia Review and Arcoxia Label ), OXYBUTYNIN CHLORIDE (Unk) (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), ZYPREXA (Unk) (View Zyprexa Review and Zyprexa Label ), CITALOPRAM HYDROBROMIDE (Unk) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6810201-0 | Acute Prerenal Failure, Dehydration, Disorientation, Hemiparesis, Hypernatraemia, Hypophagia, Nausea
on Jun 25, 2010 Female patient from GERMANY , 84 years of age, was diagnosed with hypertension, pain (What is pain?), osteoporosis (What is osteoporosis?), depression (What is depression?), prophylaxis and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: acute prerenal failure, dehydration, disorientation, hemiparesis, hypernatraemia, hypophagia, nausea (What is nausea?). Altace dosage: 5 Mg, Qd. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TORSEMIDE (10 Mg, Qd) (View Torsemide Review and Torsemide Label ), XIPAMIDE (20 Mg, Qd) (View Xipamide Review and Xipamide Label ), DURAGESIC 100 (25 Mg, Qd) (View Duragesic-100 Review and Duragesic-100 Label ), ACTONEL (35 Mg, Unk) (View Actonel Review and Actonel Label ), AMITRIPTYLINE (25 Mg, Unk) (View Amitriptyline Review and Amitriptyline Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), CALCIUM D3 STADA (Unk %, Unk) (View Calcium D3 Stada Review and Calcium D3 Stada Label ). Patient was hospitalized.

6810200-9 | Abdominal Hernia, Activities Of Daily Living Impaired, Asthenia, Bronchitis, Cough, Dyspnoea, Fatigue, Lethargy, Malaise
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal hernia, activities of daily living impaired, asthenia, bronchitis (What is bronchitis?), cough, dyspnoea, fatigue, lethargy, malaise on Jun 22, 2010 from CANADA Additional patient health information: Male patient , 59 years of age, . Altace dosage: Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6810199-5 | Confusional State, Delirium
Adverse event was reported on Jun 23, 2010 by a Female patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with myocardial infarction and. Location: UNITED KINGDOM , 75 years of age, weighting 165.3 lb, Patient had the following side effects: confusional state, delirium. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.

6810198-3 | Blood Creatinine Increased, Cardiac Failure, Diabetic Nephropathy, Dyspnoea, Hyperkalaemia, Nephropathy Toxic, Oedema, Renal Failure Acute, Renal Impairment
on Jun 25, 2010 Male patient from GERMANY , 61 years of age, was diagnosed with catheterisation cardiac, sedation and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: blood creatinine increased, cardiac failure, diabetic nephropathy, dyspnoea, hyperkalaemia, nephropathy toxic, oedema, renal failure acute, renal impairment. Altace dosage: 5 Mg, Bid. During the same period patient was treated with SPIRONOLACTONE (50 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), XENETIX (81387 Mg, Single) (View Xenetix Review and Xenetix Label ), PROPOFOL (80 Mg, Single) (View Propofol Review and Propofol Label ). Patient was hospitalized.

6807681-3 | Angioedema
on Jun 28, 2010 Female patient from UNITED STATES , weighting 213.0 lb, was diagnosed with hypertension and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Altace dosage: 2.5 Mg One A Day Po.

6803719-8 | Epistaxis, Peripheral Sensorimotor Neuropathy, Peripheral Sensory Neuropathy, Renal Failure Chronic
Patient was taking Altace (View Usage). Patient had the following side effects: epistaxis, peripheral sensorimotor neuropathy, peripheral sensory neuropathy, renal failure chronic on Jun 18, 2010 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with hypertension, peripheral sensory neuropathy, lung disorder and. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), TEGELINE (10 G, Tid) (View Tegeline Review and Tegeline Label ), LOVENOX (4000 Iu, Unk) (View Lovenox Review and Lovenox Label ), BACTRIM (Unk) (View Bactrim Review and Bactrim Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), RISORDAN (View Risordan Review and Risordan Label ). Patient was hospitalized.

6803718-6 | Agranulocytosis, Complications Of Transplanted Kidney, Cough, Lymphopenia, Neutropenia, Productive Cough, Pyrexia, Rhinorrhoea
Adverse event was reported on Jun 21, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with infection (What is infection?) and. Location: FRANCE , 47 years of age, After Altace was administered, patient had the following side effects: agranulocytosis, complications of transplanted kidney, cough, lymphopenia, neutropenia, productive cough, pyrexia, rhinorrhoea. During the same period patient was treated with CELLCEPT (1.25 G, Bid) (View Cellcept Review and Cellcept Label ), ESOMEPRAZOLE (40 Mg, Qd) (View Esomeprazole Review and Esomeprazole Label ), AMOXICILLIN (1 G, Bid) (View Amoxicillin Review and Amoxicillin Label ), NEORAL (Unk) (View Neoral Review and Neoral Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), EPOETIN BETA (Unk) (View Epoetin Beta Review and Epoetin Beta Label ), PRAVASTATIN SODIUM (Unk) (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

6803717-4 | Arthritis, Arthropathy, Bone Cyst, Bone Pain, Multiple Fractures, Neuropathy Peripheral, Sensory Loss
on Jun 17, 2010 Female patient from CANADA , 37 years of age, was diagnosed with renal disorder and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), arthropathy, bone cyst, bone pain, multiple fractures, neuropathy peripheral, sensory loss. Altace dosage: 10 Mg, Qd. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ).

6803715-0 | Inflammation, Localised Oedema, Neck Pain, Weight Increased
on Jun 21, 2010 Female patient from FRANCE , 63 years of age, was diagnosed with hypertension, type 2 diabetes mellitus, prophylaxis, gastric ulcer, pulmonary arterial hypertension, arrhythmia (What is arrhythmia?), cardiac failure and was treated with Altace (View Usage). Patient had the following side effects: inflammation, localised oedema, neck pain, weight increased. Altace dosage: 3.25 Mg, Qd. During the same period patient was treated with BYETTA (5 Mcg, Tid) (View Byetta Review and Byetta Label ), ROSUVASTATIN (10 Mg, Qd) (View Rosuvastatin Review and Rosuvastatin Label ), NEXIUM (20 Mg, Qd) (View Nexium Review and Nexium Label ), REVATIO (60 Mg, Unk) (View Revatio Review and Revatio Label ), PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ), HEMIGOXINE NATIVELLE (0.125 Mg, Unk) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LASIX (500 Mg, Unk) (View Lasix Review and Lasix Label ), HUMALOG (4.8 Iu In One Hour, Unk) (View Humalog Review and Humalog Label ). Patient was hospitalized.

6800761-8 | Contusion, Dizziness, Fall, Hemiparesis, Hypotension, Unresponsive To Stimuli
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: contusion, dizziness (What is dizziness?), fall (What is fall?), hemiparesis, hypotension, unresponsive to stimuli on Jun 21, 2010 from GERMANY Additional patient health information: Female patient , 67 years of age, . Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), SPIRONOLACTONE (50 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), CONCOR (10 Mg, Qd) (View Concor Review and Concor Label ), RISPERDAL (4 Mg, Qd) (View Risperdal Review and Risperdal Label ), MELPERONE (25 Mg, Qd) (View Melperone Review and Melperone Label ). Patient was hospitalized.

6794542-1 | Dermatitis Bullous, Dermatomyositis, Erythema, Face Oedema, Folliculitis, Impetigo, Inflammation, Lymphopenia, Muscle Atrophy
Adverse event was reported on Jun 18, 2010 by a Male patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with pain (What is pain?) and. Location: FRANCE , 49 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis bullous, dermatomyositis, erythema, face oedema, folliculitis, impetigo (What is impetigo?), inflammation, lymphopenia, muscle atrophy. During the same period patient was treated with TOPALGIC (50 Mg, Qid) (View Topalgic Review and Topalgic Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), INDOCIN (Unk) (View Indocin Review and Indocin Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6783354-0 | Breast Pain, Diabetes Mellitus Inadequate Control, Erectile Dysfunction, Glycosylated Haemoglobin Increased, Gynaecomastia, Loss Of Libido, Weight Increased
on Jun 15, 2010 Male patient from FRANCE , 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Altace (View Usage). Patient had the following side effects: breast pain, diabetes mellitus inadequate control, erectile dysfunction (What is erectile dysfunction?), glycosylated haemoglobin increased, gynaecomastia, loss of libido, weight increased. Altace dosage: 2.5 Mg, Bid. During the same period patient was treated with PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), KARDEGIC (160 Mg, Qd) (View Kardegic Review and Kardegic Label ), CARDENSIEL (2.5 Mg, Bid) (View Cardensiel Review and Cardensiel Label ), TAHOR (40 Mg, Qd) (View Tahor Review and Tahor Label ), INSULIN DETEMIR (Unk) (View Insulin Detemir Review and Insulin Detemir Label ). Patient was hospitalized.

6783353-9 | Acute Myocardial Infarction, Asthenia, Hyperkalaemia, Hypotension, Vision Blurred
on Jun 17, 2010 Female patient from ITALY , 65 years of age, was diagnosed with hypertension, ischaemic cardiomyopathy, thrombosis prophylaxis, type 2 diabetes mellitus and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: acute myocardial infarction, asthenia, hyperkalaemia, hypotension, vision blurred. Altace dosage: 5 Mg, Qd. During the same period patient was treated with KANRENOL (100 Mg, Qd) (View Kanrenol Review and Kanrenol Label ), DILATREND (6.25 Mg, Qd) (View Dilatrend Review and Dilatrend Label ), CLOPIDOGREL BISULFATE (Unk) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), NOVOMIX (View Novomix Review and Novomix Label ). Patient was hospitalized.

6783343-6 | Dermatomyositis, Muscular Weakness, Myalgia, Myopathy, Periorbital Oedema, Rash, Skin Atrophy, Skin Exfoliation
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: dermatomyositis, muscular weakness, myalgia, myopathy, periorbital oedema, rash (What is rash?), skin atrophy, skin exfoliation on Jun 14, 2010 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with hypertension and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with COLCHYSAT (Unk) (View Colchysat Review and Colchysat Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6783342-4 | Blood Creatinine Increased, Blood Sodium Decreased, Hyperkalaemia, Musculoskeletal Stiffness, Parkinson's Disease, Renal Failure
Adverse event was reported on Jun 15, 2010 by a Male patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with hypertension, oedema peripheral and. Location: GERMANY , 69 years of age, Patient had the following side effects: blood creatinine increased, blood sodium decreased, hyperkalaemia, musculoskeletal stiffness, parkinson's disease (What is parkinson's disease?), renal failure. During the same period patient was treated with FELODIPINE (2.5 Mg, Qd) (View Felodipine Review and Felodipine Label ), SPIRONOLACTONE (50 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ARELIX (Unk) (View Arelix Review and Arelix Label ), STALEVO 100 (Unk) (View Stalevo 100 Review and Stalevo 100 Label ), CARBIDOPA + LEVODOPA (Unk) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), SELEGILIN (Unk) (View Selegilin Review and Selegilin Label ). Patient was hospitalized.

6783340-0 | Atrial Flutter, Palpitations, Ventricular Tachycardia
on Jun 14, 2010 Male patient from CROATIA (local name: Hrvatska) , 71 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: atrial flutter, palpitations, ventricular tachycardia. Altace dosage: 5 Mg Qd. During the same period patient was treated with FELODIPINE (5 Mg, Qd) (View Felodipine Review and Felodipine Label ), PHYSIOTENS (0.4mg, Qam) (View Physiotens Review and Physiotens Label ). Patient was hospitalized.

6783339-4 | Sinus Arrest, Sinus Bradycardia
on Jun 15, 2010 Male patient from FRANCE , 69 years of age, was diagnosed with cardiac failure and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: sinus arrest, sinus bradycardia. Altace dosage: 5 Mg, Qd. During the same period patient was treated with PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6783338-2 | Hypertensive Crisis, Hyponatraemia, Malaise, Restlessness
Patient was taking Altace (View Usage). Patient had the following side effects: hypertensive crisis, hyponatraemia, malaise, restlessness on Jun 14, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with hypertension, depression (What is depression?), pain (What is pain?), reflux oesophagitis, hypercholesterolaemia, sleep disorder (What is sleep disorder?) and. Altace dosage: 20 Mg, Qd. During the same period patient was treated with TRIMIPRAMINE MALEATE (25 Mg, Qd) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), TELMISARTAN AND HYDROCHLOROTHIAZIDE (1 Df, Qd) (View Telmisartan And Hydrochlorothiazide Review and Telmisartan And Hydrochlorothiazide Label ), TRAMADOL HCL (300 Mg, Qd) (View Tramadol Hcl Review and Tramadol Hcl Label ), METOPROLOL TARTRATE (50 Mg, Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PANTOPRAZOLE SODIUM (20 Mg, Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SIMVASTATIN (200 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), ZOLPIDEM (10 Mg, Unk) (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6778956-1 | Bedridden, Chills, Decreased Appetite, Dehydration, Dizziness Postural, Dysuria, Flank Pain, Hyponatraemia
Adverse event was reported on Jun 09, 2010 by a Female patient taking Altace (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with essential hypertension, colitis ulcerative and. Location: SWITZERLAND , 69 years of age, After Altace was administered, patient had the following side effects: bedridden, chills, decreased appetite, dehydration, dizziness postural, dysuria, flank pain, hyponatraemia. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IMUREK (50 Mg, Bid) (View Imurek Review and Imurek Label ), CONCOR (View Concor Review and Concor Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6778955-X | Aplastic Anaemia, Brain Natriuretic Peptide Increased, Chest Pain, Dyspnoea Exertional, Hyperkalaemia, Renal Failure Acute
on Jun 07, 2010 Female patient from FRANCE , 88 years of age, was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, brain natriuretic peptide increased, chest pain (What is chest pain?), dyspnoea exertional, hyperkalaemia, renal failure acute. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with LASIX (40 Mg, Qam) (View Lasix Review and Lasix Label ), PREVISCAN (5 Mg (1/4 Of 20 Mg), Unk) (View Previscan Review and Previscan Label ), CARDENSIEL (2.5 Mg, Qd) (View Cardensiel Review and Cardensiel Label ), KALEORID (1200 (2, 600 Mg Doses)) (View Kaleorid Review and Kaleorid Label ), TAHOR (10 Mg, Unk) (View Tahor Review and Tahor Label ). Patient was hospitalized.

6778953-6 | Abdominal Pain Upper, Dizziness, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Malaise, Nausea
on Jun 07, 2010 Female patient from SPAIN , 76 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with Altace (View Usage). Patient had the following side effects: abdominal pain upper, dizziness (What is dizziness?), hyponatraemia, inappropriate antidiuretic hormone secretion, malaise, nausea (What is nausea?). Altace dosage: 5 Mg, Qd, Unk. During the same period patient was treated with METFORMIN HCL (850 Mg At Lunch, 425 Mg At Dinner) (View Metformin Hcl Review and Metformin Hcl Label ), AMILORIDE HCL AND HYDROCHLOROTHIAZIDE (5/50 Mg, Qd) (View Amiloride Hcl And Hydrochlorothiazide Review and Amiloride Hcl And Hydrochlorothiazide Label ), GLUCOSAMINE (1500 Mg, Qd) (View Glucosamine Review and Glucosamine Label ), TRIMETAZIDINE (20 Mg, Every 8 Hours) (View Trimetazidine Review and Trimetazidine Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6778952-4 | Angioedema, Increased Bronchial Secretion, Local Swelling, Stridor, Swelling Face, Swollen Tongue
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: angioedema, increased bronchial secretion, local swelling, stridor, swelling face, swollen tongue on Jun 09, 2010 from GERMANY Additional patient health information: Male patient , 69 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with LIRAGLUTIDE (6 Mg, Qd) (View Liraglutide Review and Liraglutide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BAYMYCARD (View Baymycard Review and Baymycard Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6778951-2 | Dysgeusia, Mucosal Dryness, Oral Discomfort
Adverse event was reported on Jun 09, 2010 by a Female patient taking Altace (View Usage) (Dosage: 7.5 Mg, Qd) . Location: GERMANY , 52 years of age, Patient experienced the following unwanted or unexpected effects: dysgeusia, mucosal dryness, oral discomfort. During the same period patient was treated with GASTROZEPIN (View Gastrozepin Review and Gastrozepin Label ), AMITRIPTYLINE (Unk) (View Amitriptyline Review and Amitriptyline Label ), RESTEX (Unk) (View Restex Review and Restex Label ), TILIDINE (View Tilidine Review and Tilidine Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), FEMARA (Unk) (View Femara Review and Femara Label ).

6778950-0 | Anaphylactic Shock, Dyspnoea, Respiratory Disorder
on Jun 09, 2010 Female patient from GERMANY , 87 years of age, was diagnosed with depression (What is depression?) and was treated with Altace (View Usage). Patient had the following side effects: anaphylactic shock, dyspnoea, respiratory disorder. Altace dosage: Unk. During the same period patient was treated with REMERGIL (15 Mg, Qd) (View Remergil Review and Remergil Label ).

6778894-4 | Asthenia, Hypotension, Melaena, Rectal Haemorrhage, Somnolence
on Jun 09, 2010 Male patient from GERMANY , 83 years of age, was diagnosed with renal failure, coronary artery disease (What is coronary artery disease?), depression (What is depression?), benign prostatic hyperplasia, atrial fibrillation (What is atrial fibrillation?), anaemia, type 2 diabetes mellitus, hypokalaemia and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: asthenia, hypotension, melaena, rectal haemorrhage, somnolence. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with CLOPIDOGREL BISULFATE (75 Mg, Qd) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), CITALOPRAM HYDROBROMIDE (40 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), TAMSULOSIN HYDROCHLORIDE (0.4 Mg, Qd) (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), MARCUMAR (Unk) (View Marcumar Review and Marcumar Label ), FERROUS SULFATE TAB (1 Df, Bid) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), GLUCOBAY (50 Mg, Tid) (View Glucobay Review and Glucobay Label ), KALINOR (1 Df, Qd) (View Kalinor Review and Kalinor Label ). Patient was hospitalized.

6778893-2 | Bronchitis, Thrombocytopenia
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), thrombocytopenia on Jun 15, 2010 from FRANCE Additional patient health information: Male patient , 67 years of age, . Altace dosage: 1.25 Mg, Bid. During the same period patient was treated with PRISTINAMYCIN (1 G, Tid) (View Pristinamycin Review and Pristinamycin Label ), LASIX (40 Mg, Bid) (View Lasix Review and Lasix Label ), XATRAL (10 Mg, Unk) (View Xatral Review and Xatral Label ), DIGITALINE NATIVELLE (0.25 Mg, Qd) (View Digitaline Nativelle Review and Digitaline Nativelle Label ), PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ), ISOPTIN (40 Mg, Bid) (View Isoptin Review and Isoptin Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6760958-2 | Cerebellar Atrophy, Dehydration, Depressed Level Of Consciousness, Disorientation, Dry Skin, Erythema, Excoriation, Fall
Adverse event was reported on Jun 01, 2010 by a Female patient taking Altace (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with hypertension, stress urinary incontinence, vascular dementia and. Location: GERMANY , 84 years of age, Patient had the following side effects: cerebellar atrophy, dehydration, depressed level of consciousness, disorientation, dry skin, erythema, excoriation, fall (What is fall?). During the same period patient was treated with SPIRONOLACTONE (25 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), XIPAMIDE (10 Mg, Qd) (View Xipamide Review and Xipamide Label ), TORSEMIDE (5 Mg, Qd) (View Torsemide Review and Torsemide Label ), MICTONORM (15 Mg, Qd) (View Mictonorm Review and Mictonorm Label ), MELPERONE (25 Mg, Qd) (View Melperone Review and Melperone Label ), BIPERIDEN HYDROCHLORIDE (Unk) (View Biperiden Hydrochloride Review and Biperiden Hydrochloride Label ), ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6757607-6 | Dermatitis Bullous, Dermatomyositis, Erythema, Face Oedema, Folliculitis, Impetigo, Inflammation, Lymphopenia, Muscle Atrophy
on May 26, 2010 Male patient from FRANCE , 49 years of age, was diagnosed with pain (What is pain?) and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: dermatitis bullous, dermatomyositis, erythema, face oedema, folliculitis, impetigo (What is impetigo?), inflammation, lymphopenia, muscle atrophy. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with TOPALGIC (50 Mg, Qid) (View Topalgic Review and Topalgic Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), INDOCIN (Unk) (View Indocin Review and Indocin Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6757606-4 | Renal Failure Acute
on Jun 01, 2010 Male patient from FRANCE , 89 years of age, was diagnosed with hypertension, acute pulmonary oedema and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with LASIX (125 Mg, Qd) (View Lasix Review and Lasix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), TEMERIT (View Temerit Review and Temerit Label ). Patient was hospitalized.

6750242-5 | Circulatory Collapse, Clostridial Infection, Laryngeal Inflammation, Leukopenia, Pain In Extremity
Patient was taking Altace (View Usage). Patient had the following side effects: circulatory collapse, clostridial infection, laryngeal inflammation, leukopenia, pain in extremity on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with laryngeal cancer and. Altace dosage: 5 Mg, Qd. During the same period patient was treated with DOCETAXEL (75 Mg/m2, Cyclical) (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (750 Mg/m2, Cyclical) (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (75 Mg/m2, Cyclical) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6750158-4 | Circulatory Collapse, Clostridial Infection, Laryngeal Inflammation, Leukopenia, Pain In Extremity
Adverse event was reported on May 21, 2010 by a Male patient taking Altace (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with laryngeal cancer and. Location: UNITED STATES , 69 years of age, After Altace was administered, patient had the following side effects: circulatory collapse, clostridial infection, laryngeal inflammation, leukopenia, pain in extremity. During the same period patient was treated with DOCETAXEL (75 Mg/m2, Cyclical) (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (750 Mg/m2, Cyclical) (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (75 Mg/m2, Cyclical) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6750105-5 | Abdominal Pain Upper, Dizziness, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Malaise, Nausea
on May 26, 2010 Female patient from SPAIN , 76 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dizziness (What is dizziness?), hyponatraemia, inappropriate antidiuretic hormone secretion, malaise, nausea (What is nausea?). Altace dosage: 5 Mg, Qd, Unk. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMILORIDE HCL AND HYDROCHLOROTHIAZIDE (View Amiloride Hcl And Hydrochlorothiazide Review and Amiloride Hcl And Hydrochlorothiazide Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6745725-8 | Bronchitis, Dehydration, Diarrhoea, Gastrointestinal Infection, Hyponatraemia, Nausea
on May 20, 2010 Male patient from GERMANY , 74 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), dehydration, diarrhoea, gastrointestinal infection, hyponatraemia, nausea (What is nausea?). Altace dosage: 5 Mg, Qd. During the same period patient was treated with ZOLEDRONIC ACID (Unk) (View Zoledronic Acid Review and Zoledronic Acid Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), NALOXONE HYDROCHLORIDE W/TILIDINE HYDROCHLO. (View Naloxone Hydrochloride W/tilidine Hydrochlo. Review and Naloxone Hydrochloride W/tilidine Hydrochlo. Label ), NOVAMINSULFON (View Novaminsulfon Review and Novaminsulfon Label ). Patient was hospitalized.

6743083-6 | Cardiac Failure, Dehydration, Depressed Level Of Consciousness, Diarrhoea, Fluid Intake Reduced, Hypotension, Pneumonia, Renal Failure Acute
Patient was taking Altace (View Usage). After Altace was administered, patient had the following side effects: cardiac failure, dehydration, depressed level of consciousness, diarrhoea, fluid intake reduced, hypotension, pneumonia (What is pneumonia?), renal failure acute on May 17, 2010 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with hypertension, renal failure chronic, cardiac failure chronic and. Altace dosage: 2.5 Mg, Qd. During the same period patient was treated with BISOPROLOL FUMARATE (5 Mg, Bid) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SPIRONOLACTONE (50 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (5 Mg, Qd) (View Torasemide Review and Torasemide Label ), HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6737928-3 | Aortic Valve Stenosis
Adverse event was reported on May 12, 2010 by a Female patient taking Altace (View Usage) (Dosage: 3.75 Mg, Qd) . Location: AUSTRALIA , 64 years of age, Patient experienced the following unwanted or unexpected effects: aortic valve stenosis.

6736769-0 | Asphyxia, Blood Glucose Increased, Epiglottic Oedema, Laryngeal Oedema, Pharyngeal Oedema, Red Blood Cell Sedimentation Rate Increased, Tongue Oedema
on May 13, 2010 Female patient from CROATIA (local name: Hrvatska) , 75 years of age, was diagnosed with hypertension and was treated with Altace (View Usage). Patient had the following side effects: asphyxia, blood glucose increased, epiglottic oedema, laryngeal oedema, pharyngeal oedema, red blood cell sedimentation rate increased, tongue oedema. Altace dosage: 5 Mg, Qd. During the same period patient was treated with LACIPIL (4 Mg, Qd) (View Lacipil Review and Lacipil Label ), ESTRACYT (4 U, Qd) (View Estracyt Review and Estracyt Label ). Patient was hospitalized.

6733439-X | Anaemia, Inflammation, Leukopenia, Neutropenia
on May 12, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with arthritis bacterial and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: anaemia, inflammation, leukopenia, neutropenia. Altace dosage: 1.25 Mg, Unk. During the same period patient was treated with OFLOCET (Unk) (View Oflocet Review and Oflocet Label ), RIFADIN (Unk) (View Rifadin Review and Rifadin Label ), ESOMEPRAZOLE (Unk) (View Esomeprazole Review and Esomeprazole Label ), TRIFLUCAN (Unk) (View Triflucan Review and Triflucan Label ), VASTAREL (Unk) (View Vastarel Review and Vastarel Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FENOFIBRATE (Unk) (View Fenofibrate Review and Fenofibrate Label ), ASPEGIC 1000 (Unk) (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

6733438-8 | Ecchymosis, Erysipelas, Erythema, Feeling Hot, Pain In Extremity, Vascular Purpura
Patient was taking Altace (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, erysipelas, erythema, feeling hot, pain in extremity, vascular purpura on May 11, 2010 from FRANCE Additional patient health information: Male patient , 80 years of age, . Altace dosage: Unk. During the same period patient was treated with CORDARONE (200 Mg, Qd) (View Cordarone Review and Cordarone Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), CARDENSIEL (Unk) (View Cardensiel Review and Cardensiel Label ), ESOMEPRAZOLE (Unk) (View Esomeprazole Review and Esomeprazole Label ), ROSUVASTATIN (Unk) (View Rosuvastatin Review and Rosuvastatin Label ). Patient was hospitalized.

6733434-0 | Facial Bones Fracture, Fall, Hyperkalaemia
Adverse event was reported on May 14, 2010 by a Female patient taking Altace (View Usage) (Dosage: 10 Mg, Unk) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: SWEDEN , 79 years of age, Patient had the following side effects: facial bones fracture, fall (What is fall?), hyperkalaemia. During the same period patient was treated with SPIRONOLACTONE (Unk) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6731908-X | Dizziness Postural, Fall, Hypokalaemia, Hyponatraemia, Loss Of Consciousness, Prothrombin Time Prolonged, Syncope
on May 10, 2010 Male patient from GERMANY , 79 years of age, was diagnosed with hypertension, cardiac failure, hyperuricaemia, pain (What is pain?), gastrointestinal motility disorder, duodenal ulcer and was treated with Altace (View Usage). After Altace was administered, patient had the following side effects: dizziness postural, fall (What is fall?), hypokalaemia, hyponatraemia, loss of consciousness, prothrombin time prolonged, syncope. Altace dosage: 1.25 Mg, Qd. During the same period patient was treated with FALITHROM (Unk) (View Falithrom Review and Falithrom Label ), TORASEMIDE (10 Mg, Qd) (View Torasemide Review and Torasemide Label ), XIPAMIDE (5 Mg, Qd) (View Xipamide Review and Xipamide Label ), SPIRONOLACTONE (25 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), ALLOPURINOL (300 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), METAMIZOL NATRIUM (500 Mg, Unk) (View Metamizol Natrium Review and Metamizol Natrium Label ), METOCLOPRAMIDE (5.33 Mg, Tid) (View Metoclopramide Review and Metoclopramide Label ), PANTOZOL /01263202/ (40 Mg, Unk) (View Pantozol /01263202/ Review and Pantozol /01263202/ Label ). Patient was hospitalized.

6731907-8 | Arthritis, Bone Cyst, Hypokinesia, Multiple Fractures
on May 10, 2010 Female patient from CANADA , 37 years of age, was diagnosed with renal disorder and was treated with Altace (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), bone cyst, hypokinesia, multiple fractures. Altace dosage: 10 Mg, Qd. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ).

6731905-4 | Headache, Hypertensive Crisis, Malignant Hypertension, Vision Blurred
Patient was taking Altace (View Usage). Patient had the following side effects: headache (What is headache?), hypertensive crisis, malignant hypertension, vision blurred on May 11, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 231.5 lb, was diagnosed with hypertension, essential hypertension, osteoarthritis (What is osteoarthritis?) and. Altace dosage: 2.5 Mg, Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ARCOXIA (60 Mg, Qd) (View Arcoxia Review and Arcoxia Label ), PHENPROCOUMON (Unk) (View Phenprocoumon Review and Phenprocoumon Label ).